Gradientech
PrivateLast Round
Private Placement
Mar 26, 2026
Est. Valuation
$51.88M
Total Funding Raised
$1.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gradientech is a diagnostics company that develops and provides a microfluidics-based system for ultra-rapid antibiotic susceptibility testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gradientech Comparables
Compare Gradientech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinity Biosensors | 88% | |
| SeLux Diagnostics | 87% | |
| QuantaMatrix Inc. | 87% |
Gradientech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 26, 2026 | ||||
| Private Placement | Feb 5, 2025 | ||||
| Private Placement | Sep 24, 2024 | ||||
| Private Placement | Jul 4, 2024 | ||||
| Private Placement | Nov 13, 2023 | ||||
Convertible Debt | Jul 12, 2023 |
Key People
Founding team and executive leadership
Gradientech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | VC Round |
| CBC Investment Group | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 90% MoM.
- Mar 26, 2026
Raised $5.21M in a Rights Issue round.
Recent news
Latest coverage and updates
- launchesOct 20, 2026
Gradientech launches QuickMIC(R) GN02, an IVDR CE-marked rapid antibiotic susceptibility testing panel for challenging Gram-negative pathogens that delivers susceptibility results in 3 hours and 14 minutes, on Oct 20th '26.
- hiresAug 4, 2026
Gradientech appointed Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growth, effective Aug 1st '26.
Gradientech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gradientech's valuation, stock price, and market status.
Is Gradientech a public or private company?
Gradientech is a private company.
What is the current stock price of Gradientech?
Gradientech is a private company, so its shares have no public market price. Caplight tracks Gradientech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gradientech worth (valuation)?
Gradientech's valuation is estimated at $51.9M based on funding round data.
Can I buy Gradientech stock?
Gradientech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gradientech's last funding round?
Gradientech's most recent funding round was Private Placement on March 26, 2026.
Who are the main investors in Gradientech?
Key investors in Gradientech include Almi Invest AB, CBC Investment Group.
Will Gradientech IPO soon?
No public IPO plans have been announced for Gradientech.
How can I track Gradientech secondary market activity?
Caplight tracks bids, offers, and trades in Gradientech's shares on secondary markets.